Integra LifeSciences Holdings C (IART) Financials
IART Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 3.8 billion | 2.2 billion |
| 2023-09-30 | 3.7 billion | 2.2 billion |
| 2023-06-30 | 3.8 billion | 2.1 billion |
| 2023-03-31 | 3.7 billion | 2.1 billion |
IART Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 34.2 million | 5.8 million |
| 2023-09-30 | 13.7 million | 5.5 million |
| 2023-06-30 | 12.7 million | 5.3 million |
| 2023-03-31 | 12.5 million | 3.6 million |
IART Net Income
Graph available only for supporters. Become a supporter to see it.
| Date | Net Income |
|---|---|
| 2023-12-31 | 19.8 million |
| 2023-09-30 | 19.5 million |
| 2023-06-30 | 4.2 million |
| 2023-03-31 | 24.2 million |
IART Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 309.1 million | - | 182.1 million |
| 2023-09-30 | 273.7 million | - | 182.5 million |
| 2023-06-30 | 309.2 million | 1.3 billion | 174.2 million |
| 2023-03-31 | 307.4 million | 1.3 billion | 171.7 million |
IART Shares Outstanding
IART Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 24.5 million | 24.3 million | 163.1 million | - |
| 2023-09-30 | 13.1 million | 26.6 million | 161.9 million | - |
| 2023-06-30 | 15.5 million | 26.6 million | 164.9 million | - |
| 2023-03-31 | 13.7 million | 26.7 million | 166.7 million | - |
IART Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 397.0 million | 163.1 million |
| 2023-09-30 | 382.4 million | 164.1 million |
| 2023-06-30 | 381.3 million | 174.2 million |
| 2023-03-31 | 380.8 million | 148.0 million |
IART
Price: $29.18
52 week price:
Earnings Per Share: 0.84 USD
P/E Ratio: 36.28
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Volume: 405021
Ebitda: 31.0 millionMarket Capitalization: 2.5 billion